Having trouble accessing articles? Reset your cache.

Pradaxa dabigatran etexilate regulatory update

The U.K.'s NICE asked for additional information on the cost-effectiveness of Pradaxa dabigatran from Boehringer before recommending the

Read the full 182 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE